The Enterprise Value as of November 2024 (TTM) for Anika Therapeutics, Inc. (ANIK) is 213.70M

According to Anika Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 213.70M. This represents a change of -34.47% compared to the average of 326.11M of the last 4 quarters.

Anika Therapeutics, Inc. (ANIK) Historical Enterprise Value (quarterly & annually)

How has ANIK Enterprise Value performed in the past?

The mean historical Enterprise Value of Anika Therapeutics, Inc. over the last ten years is 488.99M. The current 213.70M Enterprise Value has changed 4.27% with respect to the historical average. Over the past ten years (40 quarters), ANIK's Enterprise Value was at its highest in in the September 2017 quarter at 718.62M. The Enterprise Value was at its lowest in in the September 2023 quarter at 229.25M.

Anika Therapeutics, Inc. (ANIK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anika Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anika Therapeutics, Inc. (ANIK) Average Enterprise Value

How has ANIK Enterprise Value performed in the past?

The current Enterprise Value of Anika Therapeutics, Inc. (ANIK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Anika Therapeutics, Inc. (ANIK) Enterprise Value vs. Peers

How is ANIK’s Enterprise Value compared to its peers?

Anika Therapeutics, Inc.’s Enterprise Value is less than AxoGen, Inc. (637.27M), less than Orthofix Medical Inc. (829.81M), less than Surmodics, Inc. (554.56M), less than Paragon 28, Inc. (910.24M), less than Artivion, Inc. (1.49B), greater than Sight Sciences, Inc. (120.25M), less than Avanos Medical, Inc. (968.00M), less than OrthoPediatrics Corp. (611.40M), less than NeuroPace, Inc. (347.61M), less than CVRx, Inc. (310.32M), greater than ProSomnus, Inc. Common Stock (40.81M), less than Heska Corporation (1.26B),

Build a custom stock screener for Anika Therapeutics, Inc. (ANIK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anika Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anika Therapeutics, Inc. (ANIK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anika Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.